淋巴瘤病理新进展.pptxVIP

LYMPHOMA PATHOLOGY:WHAT’S NEW?;WHO 3rd Edition, 2001;Updated knowledge about the classification of lymphomas;;Paediatric FL;;Molecular/targeted therapy = Rituximab New drugs directed against various gentenic aberrations- Anti-ALK (crizotinib), -CD30, -BCL2, etc. And some new drugs targeted to signaling pathways- NFkB, mTOR, BCR, etc.;Fostamatinib;Updated knowledge about the classification of lymphomas;GCB v.s. ABC;GCB;;;EBV+ DLBCL of the elderly;EBER;EBV+ DLBCL: The cut-off of EBV+ tumor cells?;No. of cases (%);No. of cases (%);Survival of EBV+ DLBCLs with different therapeutic regimens